157 related articles for article (PubMed ID: 24217193)
1. Bisphosphonate use in patients undergoing dialysis.
Vouri SM; Blaszczyk AT
Consult Pharm; 2013 Nov; 28(11):738-41. PubMed ID: 24217193
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of bisphosphonates in osteoporosis.
Watts NB; Diab DL
J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for bisphosphonates in chronic kidney disease?
Miller PD
Semin Dial; 2007; 20(3):186-90. PubMed ID: 17555478
[TBL] [Abstract][Full Text] [Related]
4. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
5. Fracture risk and treatment in chronic kidney disease.
Connelly K; Collister D; Tangri N
Curr Opin Nephrol Hypertens; 2018 May; 27(3):221-225. PubMed ID: 29547405
[TBL] [Abstract][Full Text] [Related]
6. Bisphophonates in CKD patients with low bone mineral density.
Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Parathyroid Hormone Analogues in Combination With Bisphosphonates for the Treatment of Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
Li W; Chen W; Lin Y
Medicine (Baltimore); 2015 Sep; 94(38):e1156. PubMed ID: 26402797
[TBL] [Abstract][Full Text] [Related]
8. An integrated approach: bisphosphonate management for the treatment of osteoporosis.
Owens G; Jackson R; Lewiecki EM
Am J Manag Care; 2007 Dec; 13 Suppl 11():S290-308; quiz S309-12. PubMed ID: 18095779
[TBL] [Abstract][Full Text] [Related]
9. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
Nishida A; Ito M
Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605
[TBL] [Abstract][Full Text] [Related]
11. Management of Osteoporosis in Chronic Kidney Disease.
Nitta K; Yajima A; Tsuchiya K
Intern Med; 2017 Dec; 56(24):3271-3276. PubMed ID: 29021477
[TBL] [Abstract][Full Text] [Related]
12. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
Takeuchi Y
Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
[TBL] [Abstract][Full Text] [Related]
13. The kidney and bisphosphonates.
Miller PD
Bone; 2011 Jul; 49(1):77-81. PubMed ID: 21232648
[TBL] [Abstract][Full Text] [Related]
14. Treatment of osteoporosis in women intolerant of oral bisphosphonates.
Aspray TJ; Francis RM
Maturitas; 2012 Jan; 71(1):76-8. PubMed ID: 22079368
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
McClung M; Harris ST; Miller PD; Bauer DC; Davison KS; Dian L; Hanley DA; Kendler DL; Yuen CK; Lewiecki EM
Am J Med; 2013 Jan; 126(1):13-20. PubMed ID: 23177553
[TBL] [Abstract][Full Text] [Related]
16. What is the optimal duration of bisphosphonate therapy?
Ott SM
Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease and bisphosphonate treatment: are prescribing guidelines unnecessarily restrictive?
Courtney AE; Maxwell AP
Postgrad Med J; 2009 Jun; 85(1004):327-30. PubMed ID: 19528309
[TBL] [Abstract][Full Text] [Related]
18. Fracture prevention in postmenopausal osteoporosis: a review of treatment options.
McCarus DC
Obstet Gynecol Surv; 2006 Jan; 61(1):39-50. PubMed ID: 16359568
[TBL] [Abstract][Full Text] [Related]
19. Risk of fracture and the concomitant use of bisphosphonates with osteoporosis-inducing medications.
Nyandege AN; Slattum PW; Harpe SE
Ann Pharmacother; 2015 Apr; 49(4):437-47. PubMed ID: 25667198
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference.
Beard MK
Curr Med Res Opin; 2012 Jan; 28(1):141-7. PubMed ID: 22103779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
